PIVAC22 will cover the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, addressing how alterations to its molecular and metabolic features and to the microbiota impact the response to immunotherapy.
Abstract submission deadline: 1 June 2022